[心力衰竭的诊断和治疗]
Samira Soltani, Johann Bauersachs1
1Klinik für Kardiologie und Angiologie, Medizinische Hochschule Hannover, Carl-Neuberg-Str. 1, 30625, Hannover, Deutschland. bauersachs.johann@mh-hannover.de.
Herz
|August 25, 2025
概括
新的治疗方法,如SGLT2抑制剂和GLP-1类似物,正在改善心力衰竭的预后. 对于HFpEF患者来说,Finerenone和门干预也很有前途.
科学领域:
- 心脏病学
- 药理学
背景情况:
- 传统上,心力衰竭与保留喷射分数 (HFpEF) 的治疗重点是用利尿剂缓解症状.
- 目前的指导方针建议使用-葡萄糖相关传递体2 (SGLT2) 抑制剂,以改善HFpEF的预后,并得到EMPEROR-Preserved和DELIVER研究的支持.
研究的目的:
- 审查当前和新兴的心力衰竭治疗策略.
- 突出SGLT2抑制剂,finerenone,GLP-1类型的预后益处,以及对HFpEF的回干预措施.
主要方法:
- 关键临床试验的审查,包括EMPEROR-Preserved,DELIVER,FINEARTS-HF,STEP-HFpEF和SUMMIT.
- 对HFpEF患者心血管结果,住院,生活质量和症状负担的治疗效应分析.
主要成果:
- SGLT2 抑制剂在 HFpEF 中改善预后的I类推.
- 在FINEARTS- HF研究中,芬瑞对心血管死亡/ 住院患者产生了积极影响.
- 在肥胖的HFpEF患者中,GLP-1类似物 (STEP- HFpEF,SUMMIT) 改善了生活质量和心力衰竭事件.
- 严重的额头和三管吐治疗会影响症状负担,住院和预后.
结论:
- SGLT2 抑制剂是HFpEF预后的一个基石疗法.
- 新兴疗法包括芬和GLP-1类似物,为HFpEF管理提供了新的途径,特别是在特定的患者小组中.
- 治疗心脏膜疾病对于全面的HFpEF护理至关重要.
相关概念视频
01:30Heart Failure IV: Classification and Diagnostic Evaluation
32
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
32
01:30Heart Failure V: Medical Management
23
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
23
01:22Heart Failure VI: Adjunct Therapies
27
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
27
01:30Heart Failure VII: Nursing Interventions
139
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
139
01:29Cardiomyopathy V: Interprofessional Care
33
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
33
01:17Pathophysiology of Heart Failure
1.8K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.8K